ClinicalTrials.Veeva

Menu

Risk of Stroke in Pulmonary Embolism With a Patent Foramen Ovale (PFO) (ICEP)

C

Caen University Hospital

Status

Completed

Conditions

Pulmonary Embolism
Silent Stroke
Patent Foramen Ovale

Study type

Observational

Funder types

Other

Identifiers

NCT00831259
CHU de Caen

Details and patient eligibility

About

Pulmonary embolism is associated with a small but definite risk of paradoxical embolism in patients with a patent foramen ovale (PFO). While neurologic complications are unfrequent the incidence of clinically silent brain infarction is unknown. We will assess the rate of clinically apparent and silent cerebral embolism in patients with a pulmonary embolism (PE) in relation to the presence or not of a PFO.

Enrollment

70 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Pulmonary embolism, informed consent signed, no-contraindication to MRI

Exclusion criteria

  • contra-indication to MRI, informed consent not obtained

Trial design

70 participants in 2 patient groups

1
Description:
Incidence of silent stroke in patients with PFO
2
Description:
Incidence of silent stroke in patients without PFO

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems